DarioHealth Corp. DRIO
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
3/9
Piotroski F — financial health
-12.4
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $22.4M | -$41.7M | $12.7M | -$26.1M | $67.9M |
| 2024 | $27.0M | -$42.7M | $13.3M | -$38.7M | $72.0M |
| 2023 | $20.4M | -$59.4M | $6.0M | -$31.0M | $58.1M |
| 2022 | $27.7M | -$62.2M | $9.7M | -$48.3M | $80.0M |
| 2021 | $20.5M | -$76.8M | $4.0M | -$50.7M | $85.5M |
| 2020 | $7.6M | -$29.4M | $2.5M | -$17.9M | $28.2M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Nelson Steven Charles | President and CCO | 2025-09-11 | Grant | 30,000 | — |
| STERN ADAM K | director | 2025-09-11 | Grant | 20,000 | — |
| Leisure Lawrence B. | director | 2025-09-11 | Grant | 20,000 | — |
| Shaked Yoav | director | 2025-09-11 | Grant | 20,000 | — |
| Raphael Erez | Chief Executive Officer | 2025-09-11 | Grant | 60,000 | — |
| Franco-Yehuda Chen | Chief Financial Officer | 2025-09-11 | Grant | 5,000 | — |
| MCGRATH DENNIS M | director | 2025-09-11 | Grant | 20,000 | — |
| Karah Hila | director | 2025-09-11 | Grant | 20,000 | — |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -12.4 (distress)
- Working capital / assets 0.234
- Retained earnings / assets -4.107
- EBIT / assets -0.333
- Equity / liabilities 1.611
Source: SEC EDGAR filings · CIK 0001533998 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.